You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CD44 antibody [EPR1013Y] (ab51037)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab51037? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab51037 has been referenced in 8 publications.

  1. Rybak AP et al. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta 1813:683-94 (2011). IHC-P; Human. PubMed: 21277911
  2. Kai M et al. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method. Cancer Sci : (2011). PubMed: 21838786
  3. Neumeister V et al. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol 176:2131-8 (2010). IHC-P; Human. PubMed: 20228222
  4. Allen CE et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184:4557-67 (2010). IHC-Fr; Human. PubMed: 20220088
  5. Zhou Y et al. Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens. J Mol Biol 404:88-99 (2010). WB, ICC/IF; Human. PubMed: 20851130
  6. Li W et al. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast. Pathol Res Pract 206:828-34 (2010). IHC-P; Human. PubMed: 20977976
  7. Kang CJ et al. Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett 284:131-40 (2009). WB; Human. PubMed: 19457608
  8. Chen H et al. Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression. Br J Cancer 101:432-40 (2009). ICC/IF, IHC-P; Human. PubMed: 19603017

Publishing research using ab51037? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"